BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 19909244)

  • 1. A role for protein ubiquitination in VEGFR-2 signalling and angiogenesis.
    Rahimi N
    Biochem Soc Trans; 2009 Dec; 37(Pt 6):1189-92. PubMed ID: 19909244
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A critical role for the E3-ligase activity of c-Cbl in VEGFR-2-mediated PLCgamma1 activation and angiogenesis.
    Singh AJ; Meyer RD; Navruzbekov G; Shelke R; Duan L; Band H; Leeman SE; Rahimi N
    Proc Natl Acad Sci U S A; 2007 Mar; 104(13):5413-8. PubMed ID: 17372230
    [TBL] [Abstract][Full Text] [Related]  

  • 3. c-Cbl inhibits angiogenesis and tumor growth by suppressing activation of PLCγ1.
    Meyer RD; Husain D; Rahimi N
    Oncogene; 2011 May; 30(19):2198-206. PubMed ID: 21242968
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of c-Cbl-dependent regulation of phospholipase Cgamma1 activation in experimental choroidal neovascularization.
    Husain D; Meyer RD; Mehta M; Pfeifer WM; Chou E; Navruzbekov G; Ahmed E; Rahimi N
    Invest Ophthalmol Vis Sci; 2010 Dec; 51(12):6803-9. PubMed ID: 20592236
    [TBL] [Abstract][Full Text] [Related]  

  • 5. c-Cbl: An Important Regulator and a Target in Angiogenesis and Tumorigenesis.
    Lyle CL; Belghasem M; Chitalia VC
    Cells; 2019 May; 8(5):. PubMed ID: 31126146
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IQGAP1-dependent signaling pathway regulates endothelial cell proliferation and angiogenesis.
    Meyer RD; Sacks DB; Rahimi N
    PLoS One; 2008; 3(12):e3848. PubMed ID: 19050761
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The c-Cbl ubiquitin ligase regulates nuclear β-catenin and angiogenesis by its tyrosine phosphorylation mediated through the Wnt signaling pathway.
    Shivanna S; Harrold I; Shashar M; Meyer R; Kiang C; Francis J; Zhao Q; Feng H; Edelman ER; Rahimi N; Chitalia VC
    J Biol Chem; 2015 May; 290(20):12537-46. PubMed ID: 25784557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. VEGF-dependent tumor angiogenesis requires inverse and reciprocal regulation of VEGFR1 and VEGFR2.
    Zhang Z; Neiva KG; Lingen MW; Ellis LM; Nör JE
    Cell Death Differ; 2010 Mar; 17(3):499-512. PubMed ID: 19834490
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Eriocalyxin B, a natural diterpenoid, inhibited VEGF-induced angiogenesis and diminished angiogenesis-dependent breast tumor growth by suppressing VEGFR-2 signaling.
    Zhou X; Yue GG; Liu M; Zuo Z; Lee JK; Li M; Tsui SK; Fung KP; Sun H; Pu J; Lau CB
    Oncotarget; 2016 Dec; 7(50):82820-82835. PubMed ID: 27756875
    [TBL] [Abstract][Full Text] [Related]  

  • 10. VEGFs and receptors involved in angiogenesis versus lymphangiogenesis.
    Lohela M; Bry M; Tammela T; Alitalo K
    Curr Opin Cell Biol; 2009 Apr; 21(2):154-65. PubMed ID: 19230644
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanisms of integrin-vascular endothelial growth factor receptor cross-activation in angiogenesis.
    Mahabeleshwar GH; Feng W; Reddy K; Plow EF; Byzova TV
    Circ Res; 2007 Sep; 101(6):570-80. PubMed ID: 17641225
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PEST motif serine and tyrosine phosphorylation controls vascular endothelial growth factor receptor 2 stability and downregulation.
    Meyer RD; Srinivasan S; Singh AJ; Mahoney JE; Gharahassanlou KR; Rahimi N
    Mol Cell Biol; 2011 May; 31(10):2010-25. PubMed ID: 21402774
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NDRG1 activates VEGF-A-induced angiogenesis through PLCγ1/ERK signaling in mouse vascular endothelial cells.
    Watari K; Shibata T; Fujita H; Shinoda A; Murakami Y; Abe H; Kawahara A; Ito H; Akiba J; Yoshida S; Kuwano M; Ono M
    Commun Biol; 2020 Mar; 3(1):107. PubMed ID: 32144393
    [TBL] [Abstract][Full Text] [Related]  

  • 14. C-CBL is required for inhibition of angiogenesis through modulating JAK2/STAT3 activity in ROP development.
    Chen S; Sun Q; Sun D; Willette-Brown J; Anderson MJ; Gu Q; Lewandoski M; Hu Y; Zhu F; Wei F; Zhang J
    Biomed Pharmacother; 2020 Dec; 132():110856. PubMed ID: 33125970
    [TBL] [Abstract][Full Text] [Related]  

  • 15. VEGF receptor trafficking in angiogenesis.
    Scott A; Mellor H
    Biochem Soc Trans; 2009 Dec; 37(Pt 6):1184-8. PubMed ID: 19909243
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The ubiquitin-proteasome system meets angiogenesis.
    Rahimi N
    Mol Cancer Ther; 2012 Mar; 11(3):538-48. PubMed ID: 22357635
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myoferlin regulates vascular endothelial growth factor receptor-2 stability and function.
    Bernatchez PN; Acevedo L; Fernandez-Hernando C; Murata T; Chalouni C; Kim J; Erdjument-Bromage H; Shah V; Gratton JP; McNally EM; Tempst P; Sessa WC
    J Biol Chem; 2007 Oct; 282(42):30745-53. PubMed ID: 17702744
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-angiogenic effect of quercetin and its 8-methyl pentamethyl ether derivative in human microvascular endothelial cells.
    Lupo G; Cambria MT; Olivieri M; Rocco C; Caporarello N; Longo A; Zanghì G; Salmeri M; Foti MC; Anfuso CD
    J Cell Mol Med; 2019 Oct; 23(10):6565-6577. PubMed ID: 31369203
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The c-Cbl/CD2AP complex regulates VEGF-induced endocytosis and degradation of Flt-1 (VEGFR-1).
    Kobayashi S; Sawano A; Nojima Y; Shibuya M; Maru Y
    FASEB J; 2004 May; 18(7):929-31. PubMed ID: 15001553
    [TBL] [Abstract][Full Text] [Related]  

  • 20. c-Cbl, a ubiquitin E3 ligase that targets active β-catenin: a novel layer of Wnt signaling regulation.
    Chitalia V; Shivanna S; Martorell J; Meyer R; Edelman E; Rahimi N
    J Biol Chem; 2013 Aug; 288(32):23505-17. PubMed ID: 23744067
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.